Vol. IV · No. 19
Tuesday, June 23, 2026
Issue: Spring · 2026
Established · MMXXVI
— The evidence base for longevity medicine —
Indexed by PubMed · CTG · Cochrane
Editorial team · geroevidence.com
Subscription · app.geroevidence.com
Geroevidence · Editorial desk · Clinical Trials

Clinical Trials

Trial readouts, protocol analyses, and enrollment updates.

3 articles in this category · ← All categories
§ Clinical Trials · 3 articles
Could semaglutide become an anti-aging drug? The SELECT trial and beyond
Semaglutide's weight-loss story is well known. The cardiovascular outcome data is the more significant — and less discussed — longevity story.
June 24, 2026  ·  11 min read
Rapamycin dosing in published clinical trials: what the research has actually tested
A summary of dosing regimens used in published rapamycin longevity trials. This describes what researchers have studied — it is not a dosing recommendation.
June 24, 2026  ·  10 min read
The TAME trial explained: what metformin's biggest longevity test will actually tell us
TAME is the most significant longevity trial running. What the trial design means, what a positive result would and would not prove, and what interim signals look like.
May 10, 2026  ·  11 min read